The drumbeat of AI advancements over the last year has left us all breathless, wondering which benchmark will be broken next and which new problems we can solve in biology.
With the Federal Reserve poised to implement interest rate cuts (albeit fewer than earlier forecasts assumed) and FTC leadership turnover anticipated, there may be broader shifts in how cap
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
